IL327480A - שיטות לטיפול בניוון מקולרי - Google Patents
שיטות לטיפול בניוון מקולריInfo
- Publication number
- IL327480A IL327480A IL327480A IL32748026A IL327480A IL 327480 A IL327480 A IL 327480A IL 327480 A IL327480 A IL 327480A IL 32748026 A IL32748026 A IL 32748026A IL 327480 A IL327480 A IL 327480A
- Authority
- IL
- Israel
- Prior art keywords
- methods
- macular degeneration
- treating macular
- treating
- degeneration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363587230P | 2023-10-02 | 2023-10-02 | |
| PCT/IB2024/059630 WO2025074268A1 (en) | 2023-10-02 | 2024-10-02 | Methods for treating macular degeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL327480A true IL327480A (he) | 2026-05-01 |
Family
ID=93211862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL327480A IL327480A (he) | 2023-10-02 | 2024-10-02 | שיטות לטיפול בניוון מקולרי |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2024354759A1 (he) |
| IL (1) | IL327480A (he) |
| WO (1) | WO2025074268A1 (he) |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4405712A (en) | 1981-07-01 | 1983-09-20 | The United States Of America As Represented By The Department Of Health And Human Services | LTR-Vectors |
| US4650764A (en) | 1983-04-12 | 1987-03-17 | Wisconsin Alumni Research Foundation | Helper cell |
| JPS61502932A (ja) | 1984-05-25 | 1986-12-18 | デイナ−フア−バ−・キヤンサ−・インステイテユ−ト | Ｌｔｒベクタ−、製法及び用途 |
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US4861719A (en) | 1986-04-25 | 1989-08-29 | Fred Hutchinson Cancer Research Center | DNA constructs for retrovirus packaging cell lines |
| US4980289A (en) | 1987-04-27 | 1990-12-25 | Wisconsin Alumni Research Foundation | Promoter deficient retroviral vector |
| WO1989007150A1 (en) | 1988-02-05 | 1989-08-10 | The Trustees Of Columbia University In The City Of | Retroviral packaging cell lines and processes of using same |
| US5112767A (en) | 1988-03-04 | 1992-05-12 | University Of Southern California | Vectors with enhancer domains |
| US6677311B1 (en) | 1988-07-20 | 2004-01-13 | The Salk Institute For Biological Studies | Inducible HSV-TK in transformed cell populations |
| JP3082204B2 (ja) | 1988-09-01 | 2000-08-28 | ホワイトヘッド・インスティチュート・フォー・バイオメディカル・リサーチ | 両栄養性および環境栄養性宿主域を持つ組換え体レトロウイルス |
| WO1990002797A1 (en) | 1988-09-15 | 1990-03-22 | North Carolina State University | Self-inactivating, replication defective, retroviral vectors and helper cells for producing the same |
| US5124263A (en) | 1989-01-12 | 1992-06-23 | Wisconsin Alumni Research Foundation | Recombination resistant retroviral helper cell and products produced thereby |
| EP0471796A4 (en) | 1989-05-10 | 1993-05-05 | Sloan Kettering Institute For Cancer Research | Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter |
| WO1992005266A2 (en) | 1990-09-21 | 1992-04-02 | Viagene, Inc. | Packaging cells |
| EP0556345B2 (en) | 1990-10-31 | 2005-10-12 | Cell Genesys, Inc. | Retroviral vectors useful for gene therapy |
| US5122767A (en) | 1991-01-10 | 1992-06-16 | Northern Telecom Limited | Saw device tapped delay lines |
| DE69131908T3 (de) | 1991-02-19 | 2008-04-03 | Oxford Biomedica (Uk) Ltd. | Viruspartikel mit veraendertem wirtspektrum |
| WO1993014188A1 (en) | 1992-01-17 | 1993-07-22 | The Regents Of The University Of Michigan | Targeted virus |
| US5627264A (en) | 1994-03-03 | 1997-05-06 | Alexion Pharmaceuticals, Inc. | Chimeric complement inhibitor proteins |
| US5998205A (en) | 1994-11-28 | 1999-12-07 | Genetic Therapy, Inc. | Vectors for tissue-specific replication |
| US5851826A (en) | 1995-07-26 | 1998-12-22 | Children's Medical Center Corporation | Helper virus-free herpesvirus vector packaging system |
| US6689600B1 (en) | 1998-11-16 | 2004-02-10 | Introgen Therapeutics, Inc. | Formulation of adenovirus for gene therapy |
| JP2004536572A (ja) | 2001-02-23 | 2004-12-09 | セル・ジェネシス・インコーポレイテッド | 新規ベクター構築物 |
| US20070196367A1 (en) | 2006-02-22 | 2007-08-23 | Valentin Dinu | Methods of preventing and treating Alzheimer's disease, age related macular degeneration and other diseases involving extra-cellular debris through the inhibition of the complement system |
| WO2009032148A1 (en) | 2007-08-29 | 2009-03-12 | Tufts University | Methods of making and using a cell penetrating peptide for enhanced delivery of nucleic acids, proteins, drugs, and adenovirus to tissues and cells, and compositions and kits |
| EP2252317B1 (en) * | 2008-02-15 | 2014-04-09 | Tufts University | Treatment of macular degeneration |
| WO2012021891A2 (en) * | 2010-08-13 | 2012-02-16 | Tufts University | Compositions, kits and methods for treatment of complement-related disorders |
| KR20240107156A (ko) * | 2021-11-19 | 2024-07-08 | 얀센 바이오테크 인코포레이티드 | 가용성 cd59를 발현하는 유전자 요법 벡터를 이용한 지도형 위축의 치료 방법 |
-
2024
- 2024-10-02 IL IL327480A patent/IL327480A/he unknown
- 2024-10-02 AU AU2024354759A patent/AU2024354759A1/en active Pending
- 2024-10-02 WO PCT/IB2024/059630 patent/WO2025074268A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025074268A1 (en) | 2025-04-10 |
| AU2024354759A1 (en) | 2026-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL304275A (he) | שיטות לטיפול בסרטן | |
| IL312680A (he) | שיטות לטיפול בסרטן | |
| EP3697920A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | |
| IL267146A (he) | שיטה לטיפול בניוון מקולרי | |
| EP4259129A4 (en) | COMPOSITIONS FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION (AMD) | |
| EP3672579A4 (en) | COMPOSITIONS AND METHODS OF TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND GEOGRAPHICAL ATROPHY | |
| EP4363057A4 (en) | METHODS OF TREATING DEPRESSIVE CONDITIONS | |
| SMT202500493T1 (it) | Metodi per il trattamento dell'iperfenilalaninemia | |
| IL277779A (he) | תכשירים ושיטות לטיפול בניוון מקולרי | |
| IL280800A (he) | שיטה לטיפול בסרטן הלבלב | |
| GB202107880D0 (en) | Method | |
| ZA201904051B (en) | Peptide for treating age-related macular degeneration | |
| PL4048284T4 (pl) | Metoda leczenia nowotworów | |
| IL308393A (he) | נוגדנים לטיפול במחלות אלפא-סינוקליאיניות | |
| EP4382103A4 (en) | METHODS FOR TREATING RETINAL DEGENERATION | |
| IL284668A (he) | שיטות לטיפול בסכיזופרניה | |
| CA3306613A1 (en) | Methods for treating macular degeneration | |
| IL213550A0 (en) | Method for treating macular degeneration | |
| IL318067A (he) | תכשירים ושיטות רפואיים עבור ניוון מקולרי קשור-גיל | |
| HK40106139A (en) | Method for treating retinal degeneration | |
| EP4400576A4 (en) | CELL TREATMENT METHOD | |
| IL290351A (he) | הרכבים ושיטות לטיפול במחלות נוירולוגיות | |
| KR102593936B9 (ko) | 신규한 펩타이드를 포함하는 황반변성의 치료용 조성물 | |
| SG11202112052VA (en) | Compositions and methods for treating presbyopia | |
| EP4051437A4 (en) | PROCESS WATER TREATMENT METHODS |